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This work demonstrates data of multiple regression analysis
between nine biomarkers related to glutamate excitotoxicity and
impaired detoxiﬁcation as two mechanisms recently recorded as
autism phenotypes. The presented data was obtained by measur-
ing a panel of markers in 20 autistic patients aged 3–15 years and
20 age and gender matching healthy controls. Levels of GSH, glu-
tathione status (GSH/GSSG), glutathione reductase (GR),
glutathione-s-transferase (GST), thioredoxin (Trx), thioredoxin
reductase (TrxR) and peroxidoxins (Prxs I and III), glutamate,
glutamine, glutamate/glutamine ratio glutamate dehydrogenase
(GDH) in plasma and mercury (Hg) in red blood cells were deter-
mined in both groups. In Multiple regression analysis, R2 values
which describe the proportion or percentage of variance in the
dependent variable attributed to the variance in the independent
variables together were calculated. Moreover, β coefﬁcients values
which show the direction either positive or negative and the
contribution of the independent variable relative to the other
independent variables in explaining the variation of the dependent
variable were determined. A panel of inter-related markers was
recorded. This paper contains data related to and supporting
research articles currently published entitled “Mechanism of
nitrogen metabolism-related parameters and enzyme activities inier Inc. This is an open access article under the CC BY license
ent, Science College, King Saud University, Saudi Arabia. Tel.: þ966 1 4682184;
nsary@gmail.com
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A. El-Ansary / Data in Brief 7 (2016) 111–116112the pathophysiology of autism” [1], “Novel metabolic biomarkers
related to sulfur-dependent detoxiﬁcation pathways in autistic
patients of Saudi Arabia [2], and “A key role for an impaired
detoxiﬁcation mechanism in the etiology and severity of autism
spectrum disorders” [3].
& 2016 The Author. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Clinical Chemistry
ore speciﬁc sub-
ject areaBiomarkers of autismype of data Tables and ﬁgure
ow data was
acquiredELISA Technique analysis of blood samplesata format Analyzed data
xperimental
factorsBlood was collected in test tubes containing heparin as anticoagulant. The
samples were separated by centrifugation at 3000 rpm and 25 °C for 10min.
The plasma was removed and frozen at 80 °C until analyzed.xperimental
featuresThe selected biomarkers were measured in plasma samples of autistics and
control participantsata source
locationRiyadh, Saudi Arabia, Autism Research & Treatment Center clinicata accessibility All data is with this articleDValue of the data Identiﬁcation of novel biomarker for neurological disorders will help to increase the quality of life
of affected individuals, by providing sensitive and selective clinical correlates for the early
diagnosis.
 These markers can provide insights into disease mechanisms that can be used to identify ther-
apeutic targets and to develop efﬁcacious compounds to target them.
 Due to the complexity of the brain, a single marker is not sufﬁcient to have enough diagnostic
power and thus it is important to combine panel of markers to improve diagnosis accuracy [5].
 Among different combination approaches, the multiple regressions are easy to compute and
interpret the relationship between different recorded markers. It is a common statistical technique
to assess the relationships among two or more independent variables and their correlation with a
dependent variable.
 Screening of this panel of markers in newborns at risk for neuro-developmental disease (e.g.
autism) can help in the early diagnosis and intervention.1. Data
Table 1 demonstrates the signiﬁcant variations of the measured parameters in autistic patients
compared to healthy controls. R2 values of the multiple regression analysis for glutamate, glutamine
and glutamate/glutamine ratio as three dependent variables show that almost 100% of the changes of
Table 2
Multiple regression using stepwise method for glutamic acid (mmol/l) as a dependent variable in autistic group.
Predictor variable Beta P value Adjusted R2 Model
F value P value
Glutamine (mmol/l) 0.302 0.001 0.964 352.514 0.001
Glutamic/glutamine ratio 92.604 0.001
Peroxiredoxin 1 level (ng/
ml)
0.273 0.011
Table 1
Mean7SD of the measured chemicals in plasma or red blood cells of patients with autism compared with age-matched
controls.
Parameter Group N Mean7SD Percent
change
P value
Glutamic (mmol/l) Control 20 111.9174.51 100.00 0.001
Autistic 20 152.8076.47 136.54
Glutamine (mmol/l) Control 20 241.82712.93 100.00 0.001
Autistic 20 111.3475.69 46.04
Glutamic/Glutamine
Ratio
Control 20 0.4670.03 100.00 0.001
Autistic 20 1.3770.06 296.18
Glutamate dehy-
drogenase (GLDH)
(U/l)
Control 20 1.7170.47 100.00 0.001
Autistic 20 0.9370.36 54.22
Thioredoxin I (ng/ml) Control 20 44.7177.43 100.00 0.001
Autistic 20 74.7079.04 167.09
Thioredoxin reductase
(mU/ml)
Control 20 1.8370.52 100.00 0.001
Autistic 20 3.3171.11 180.87
Peroxiredoxin I (ng/ml) Control 20 19.5874.76 100.00 0.001
Autistic 20 34.5678.32 176.55
Peroxiredoxin III (ng/
ml)
Control 20 24.3072.69 100.00 0.001
Autistic 20 43.0575.86 177.16
GSH/GSSG Control 20 26.0775.03 100.00 0.001
Autistic 20 8.0372.46 30.79
Glutathione-s-transfer-
ase (mmol/min/ml)
Control 20 0.6970.20 100.00 0.001
Autistic 20 0.4170.12 59.26
Mercury (mg/L) Control 20 4.6470.68 100.00 0.001
Autistic 20 6.9370.74 149.40
Table 3
Multiple regression using stepwise method for glutamine (mmol/l) as a dependent variable in autistic group.
Predictor variable Beta P value Adjusted R2
square
Model
F value P value
Glutamic (mmol/l) 0.969 0.001 0.990 1243.754 0.001
Glutamic/glutamine
ratio
177.627 0.001
Thioredoxin 1 level
(ng/ml)
0.274 0.044
A. El-Ansary / Data in Brief 7 (2016) 111–116 113these variables could be easily explained and associated by the changes in oxidative stress and
detoxiﬁcation related parameters in autistic patients but not in age and gender matching control
participants (Tables 2–5). The relationship between the panels of associated biomarkers is illustrated
in Fig. 1.
Table 4
Multiple regression using stepwise method for glutamic/glutamine ratio as a dependent variable in autistic group.
Predictor variable Beta P value Adjusted R2 Model
F value P value
Glutamic (mmol/l) 0.006 0.001 0.995 1938.823 0.001
Glutamine (mmol/l) 0.005 0.001
Thioredoxin reductase
activity (mU/ml)
0.013 0.038
GSH/GSSG 0.003 0.018
Table 5
Multiple regression using stepwise method for glutamic (mmol/l) as a dependent variable in control group.
Predictor variable Beta P value Adjusted R2 Model
F value P value
Glutamic/glutamine ratio 222.768 0.001 0.996 2481.60 0.001
Glutamine (mmol/l) 0.445 0.001
A. El-Ansary / Data in Brief 7 (2016) 111–1161142. Experimental design, materials and methods
The local Ethical Committee of the Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia,
approved this study (Approval number is 11/2890/IRB). In addition, an informed written consent of
participation for this study was signed by the parents or the legal guardians of the investigated
subjects, according to the Helsinki principles. All subjects enrolled in the study (20 autistic children
and 20 control males) had ﬁlled the informed consent. They were enrolled through the ART Center
(Autism Research & Treatment Center) clinic in King Khalid University Hospital in Riyadh. The ART
Center clinic population consisted of children diagnosed on the autism spectrum disorder (ASD). The
diagnosis of ASD was conﬁrmed in all subjects using the Autism Diagnostic Interview-Revised (ADI-R)
and the Autism Diagnostic Observation Schedule (ADOS) and Developmental, dimensional diagnostic
interview (3DI). The mean of age of all autistic children participated in the study were between 774
years old. All were simplex cases. All were negative for fragile gene study. The control group
recruited from pediatric clinic at king Saud medical city in Riyadh with mean age 774 years old.
Subjects were excluded from the investigation if they had dysmorphic features, or diagnosis of fragile
X or other serious neurological (e.g., seizures), psychiatric (e.g., bipolar disorder) or known medical
conditions. All participants were screened via parental interview for current and past physical illness.
Children with known endocrine, cardiovascular, pulmonary, liver, kidney or other medical disease
were excluded from the study.
2.1. Blood samples
After an overnight fast, patients underwent blood sampling; 10 ml blood samples were collected
on ice from both groups in test tubes containing heparin as anticoagulant. The samples were sepa-
rated by centrifugation at 3000 rpm and 25 °C for 10 min. The plasma was removed and frozen at
80 °C until analyzed.3. Biochemical analyses
Glutamate and glutamine levels were assessed using an HPLC method. For measurement of glu-
tamate dehydrogenase activity, a commercial kit (Randox Laboratories Ltd., Crumlin, Co. Antrim, UK)
Fig. 1. Illustrated relationship between the associated glutamate excitotoxicity, oxidative stress and impaired detoxiﬁcation
markers in autistic patients.
A. El-Ansary / Data in Brief 7 (2016) 111–116 115was used. Thioredoxin 1 (Trx 1) together with the peroxiredoxins (Prxs I and III) was assessed using
ELISA kits, a product of northwest company. Thioredoxin reductase (TR) activity was measured using
commercially available kit (Biovision, USA). Measurement of reduced GSH, total glutathione and GSH/
GSSG ratio were assayed based on the glutathione recycling system by 5,5-dithio-bis (2-nitrobenzoic
acid) (DTNB) and glutathione reductase. The glutathione-s-transferase (GST) activity was assessed
using (Biovision, USA) assay kit. The concentration of inorganic mercury (Hg) in red blood cells was
determined using a ﬂameless atomic-absorption instrument.
3.1. Statistical analyses
Statistical Program for Social Sciences (SPSS) (SPSS Inc., Chicago, IL, USA) was used for all analyses.
Data were expressed as mean7SD. All statistical comparisons were made by means of Student’s t-
test. Po0.05 was considered signiﬁcant. Multiple regression analysis was used to ﬁnd the correlation
between the selected parameters using SPSS program [4]. In this analysis R2 describes the proportion
or percentage of variance in the dependent variable explained by the variance in the independent
variables together which sometimes called the predictor variables. An R2 of 1.00 indicates that 100% of
the variation in the dependent variable is explained by the independent variables. Conversely, an R2
of 0.0 indicates the absence of variation in the dependent variable due to the independent variables.
A. El-Ansary / Data in Brief 7 (2016) 111–116116In this work as the variables are not in the same unit of measures, a standardized regression coef-
ﬁcient, beta (β), was used. The β coefﬁcients values show the direction either positive or negative and
the contribution of the independent variable relative to the other independent variables in explaining
the variation of the dependent variable. R2 and (β) coefﬁcient provide most of what we need to
interpret our multiple regression data. Stepwise multiple regression analyses were performed using
glutamate, glutamine and glutamate/glutamine ratio as three dependent variables and Trx1, Trxre-
ductase, Prx I&III, GSH/GSSG, glutathione-s-transferase and mercury as independent variables.Acknowledgments
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